Eikon Therapeutics
Wollansa Habtu serves as the Associate Director of Clinical Development Systems at Eikon Therapeutics since April 2023. Prior experience includes serving as Associate Director of R&D BT at AbbVie from May 2020 to June 2022, where Wollansa collaborated with R&D business units to align software and information systems with strategic roadmaps. At Allergan, from 2002 to May 2020, Wollansa held various roles including Associate Director of R&D IT, Senior Manager of Business Information Management, and Project Leader, focusing on technology delivery management for clinical trial management systems and overseeing contractors on system enhancements. Wollansa holds a Bachelor of Science degree in Computer Science from California State University-Dominguez Hills.
This person is not in any teams
This person is not in any offices
Eikon Therapeutics
3 followers
Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the interface of biology, engineering and chemistry to discover novel treatments for life-threatening diseases.